A German study published Feb. 15, 2016 in
JAMA Neurology, coming on the heels of a previous study, have hoisted red flags for doctors and patients alike by documenting a 33 percent increase in dementia and 44 percent increase in Alzheimer’s disease among seniors using these acid reducing drugs.
Dosage details (amount, frequency, time taken) and 1/2 time elimination (usually prolonged in the elderly) may explain somewhat the timing.